Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm clinical trials

Explore recruiting braf v600 mutation positive melanoma with brain metastasis mbm clinical trials.

Also recruiting in Europe

Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

BEPCOME-MB: Phase 2, randomised trial testing the addition of upfront stereotactic radiosurgery to binimetinib, encorafenib plus pembrolizumab in comparison with binimetinib, encorafenib plus pembrolizumab alone in patients with BRAFV600 mutationpositive melanoma with brain metastasis

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm trials by city

Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Toronto Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Vancouver Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Montreal Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Calgary Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Edmonton Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Ottawa Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Winnipeg Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Quebec City Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Hamilton Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Kitchener Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in London Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Halifax Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in New York Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Los Angeles Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Chicago Braf V600 Mutation Positive Melanoma With Brain Metastasis Mbm in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease